Related Experiment Videos
Hemoglobin La Desirade alpha A2 beta 2 129 (H7) Ala----Val: a new unstable hemoglobin
Hemoglobin
|January 1, 1986
Abstract:
Hemoglobin La Desirade is a new unstable hemoglobin variant arising from the substitution of beta 129 (H7) Ala for Val. Hb La Desirade exhibits a low oxygen affinity and normal heme-heme interaction. The variant was found in two unrelated black families in association with Hb S, Hb C or beta o thalassemia.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Variable impact of an antimicrobial stewardship programme in three intensive care units: time-series analysis of 2012-2017 surveillance data.
The Journal of hospital infection·2019
Intrapartum group B Streptococcus screening in the labor ward by Xpert® GBS real-time PCR.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Clinical and microbiological features associated with group B Streptococcus bone and joint infections, France 2004-2014.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
A Rare Case of Hemobilia due to Hepatic Artery Pseudoaneurysm (HAPA) in the right Hepatic Artery-Segment 8 branch and its Management via Coil Embolization.
Nigerian medical journal : journal of the Nigeria Medical Association·2026
In advanced CKD with high CV risk, low-dose rivaroxaban vs. placebo did not reduce CV events and increased major bleeding.
Annals of internal medicine·2026
Echo Chambers: Bias and Representation in Cardiac Imaging Datasets for Artificial Intelligence.
Current cardiology reports·2026
Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients.
The New England journal of medicine·2026